Skip to content

Gelweave™ 734024/10SRecalls & reported problems

Vascutek Ltd · Gelweave Gelatin Impregnated Woven Vascular Prosthesis ANTE-FLO · Class 2 · Implant

All models of Gelweave (47)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05037881106502), received between Oct 20, 2020 and Oct 20, 2020 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Seroma1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 20, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2019, THE PATIENT HAD A GELWEAVE ANTE-FLO GRAFT IMPLANTED. A FOLLOW UP CT SCAN WAS PERFORMED WHICH DETECTED A SEROMA FORMATION. THE GRAFT WAS EXPLANTED ON (B)(6) 2020 WITH A TOTAL AORTIC ARCH REPLACEMENT PROCEDURE.

    Patient problems: Seroma

    MAUDE report 10703770 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page